![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.50 | 37.00 | 40.00 | 38.50 | 38.50 | 38.50 | 0 | 08:00:00 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/1/2022 22:30 | US doubles orders of Pfizer's Paxlovid to 20 million... "Big order for Pfizer's antiviral pill It comes as the US doubled its order for Pfizer's oral COVID-19 antiviral treatment. The drugs maker and the White House said 20 million courses of Paxlovid would now be procured - with four million ready by the end of January..." Bodes well for BXP's generic version... "30 December 2021 BEXIMCO PHARMACEUTICALS LTD. Beximco Pharma introduces world's first generic version of Pfizer's Paxlovid, the first US FDA approved oral therapy for COVID-19 treatment" | ![]() someuwin | |
04/1/2022 09:14 | Difficult to buy any. | ![]() someuwin | |
03/1/2022 20:28 | Hmm... I'm still sitting on these... :o) A buyout would still be nice, hopefully for £3+. In the meantime more sitting... be interesting to see how much cash they might make from Bexovid.... £3 might come quicker. I like this share because I just leave it alone and it drifts up. So we have a 179p prediction and that was before the recent RNS. :o) GLA | ![]() greg the grinch | |
01/1/2022 09:38 | Yesterday the UK approved the Pfizer pill for those with weakened immune systems, and I'd expect to see a tidal wave of further approvals globally in the coming weeks to try and keep pace with Omicron, and any future, variants. Obviously producing the world's first generic version puts Beximco right at the forefront of the fight against Covid. Also great point about the likelihood of BXP producing a vaccine, toadhall. HNY all! :) | ![]() microscope | |
31/12/2021 12:31 | We have another iron in the fire to stimulate interest. Just wait till the Co announces a plan to produce vaccines (non Covid / and possibly Covid). See the 24 th Nov RNS. No smoke without fire. | ![]() toadhall1 | |
31/12/2021 10:19 | I'm sure India in particular, with its population of about 1.4 billion, will be casting glances in Beximco's direction. Given the huge problems India has had with the Delta variant, and the fact that they provided Beximco with many millions of vaccines, further co-operation between the two would seem a logical step. | ![]() microscope | |
31/12/2021 08:54 | Nice write-up in The Times Market Report this morning. Here is an extract: Beximco Pharmaceuticals quick off the mark with clone of Pfizer’s antiviral drug "It’s been quite a year for listed pharmaceutical companies. Many have been at the forefront of the fight against coronavirus, rushing to produce vaccines in record time and in turn helping reopen economies across the world. One of those is Beximco Pharmaceuticals. The first Bangladeshi company to float on London’s junior stock market in 2005 makes cheap versions of patented drugs for sale in some of the world’s poorest countries. Its shares, which are up just over 10 per cent on this time last year, got a further boost yesterday after it launched what it claimed to be the world’s first generic version of Pfizer’s Covid-19 treatment Paxlovid. Last week the US Food and Drug Administration approved Pfizer’s antiviral pill after it proved nearly 90 per cent effective in preventing hospital admissions and deaths in high-risk patients. Beximco said it plans to launch its own version in Bangladesh under the name Bexovid. The news sent the shares to a record high, closing up 2½p, or 2.3 per cent, at 111p." | ![]() jim208 | |
30/12/2021 15:17 | .....Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces the launch of the world's first generic version of Pfizer's COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use) which was granted emergency use authorization (EUA) by the US FDA on 22 December 2021. Directorate General of Drug Administration (DGDA), Bangladesh, has today granted EUA for the oral antiviral drug to treat mild-to-moderate COVID-19 in adults and children of 12 years and above. This novel antiviral pill showed almost 90% efficacy in preventing hospitali z ations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus. Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh. | ![]() davebowler | |
30/12/2021 12:40 | What an announcement! World's first generic version of Pfizer pill. If this was a better known pharma market reaction would be off the scale. Quiet time generally for market news, hopefully we'll get very decent press coverage. Fantastic yield, chart breakout too, profitable and low enough p/e! For anybody who's not seen this.... | ![]() microscope | |
30/12/2021 11:14 | On dividend payment questions, the company did drop an RNS on Christmas Eve to say that it will be paid on or before the 20th January. My past experience is that it can take time to filter into accounts, so it may need some patience. | ![]() jim208 | |
30/12/2021 11:07 | great RNS today IMO. Hopefully, BXP can roll this out to other countries outside of Bangladesh. | ![]() mfhmfh | |
21/12/2021 16:20 | Sorry - Stocko's changed the payment date to 1/1/22 | ![]() podgyted | |
21/12/2021 16:16 | When is the dividend due to be paid - haven't rec'd mine yet | ![]() podgyted | |
10/12/2021 13:22 | Dave - thanks for that | ![]() cb7 | |
24/11/2021 21:03 | A small rise on today's vaccine media comment. Patience needed. Put in the drawer and come back late next year. | ![]() outsizeclothes.com | |
17/11/2021 00:01 | Our next Covid generic ????? | ![]() outsizeclothes.com | |
11/11/2021 12:42 | Great Q1 results. No wonder the company elected to pay the entire dividend in cash this year! And Q1 doesn’t included any vaccine uplift. Will analyse in more detail later. Solid hold | ![]() toadhall1 | |
11/11/2021 12:03 | Yes the Dividend is subject to 20% Bangladesh WHT | ![]() sayuri92 | |
09/11/2021 07:21 | Yes, unexpected but very impressive news should see a new high today.... :-) | ![]() cityfarmer | |
09/11/2021 07:15 | Launch of oral product for treating Covid.Although they don't anticipate a material impact on next numbers, if the product is approved in more countries (already approved in UK) I suspect that could and will change dramatically!Well done BXP! | ![]() microscope | |
08/11/2021 12:26 | Microscope, I'd agree that it looks like a cup and handle on the year to date chart. I'd be looking at an upwards channel as a shorter-term chart pattern, with a 105 break leading to 112 end of year target, and a June/July target of 130. | ![]() outsizeclothes.com | |
08/11/2021 12:08 | Sorry ceaser I simply don't know. Chart is close to a breakout. For the geeky, looks to me like a lovely cup and handle on the longer term chart may be completing | ![]() microscope | |
02/11/2021 19:12 | Is there withholding tax to pay on its dividend? | ![]() ceaserxzy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions